0001179110-11-016563.txt : 20111213 0001179110-11-016563.hdr.sgml : 20111213 20111213190234 ACCESSION NUMBER: 0001179110-11-016563 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111209 FILED AS OF DATE: 20111213 DATE AS OF CHANGE: 20111213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aguiar Michael W CENTRAL INDEX KEY: 0001318005 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 111259614 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0304 4 2011-12-09 0 0001080014 THERAVANCE INC THRX 0001318005 Aguiar Michael W THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Sr VP, Chief Financial Officer Common Stock 2011-12-09 4 S 0 10000 21.86 D 186774 D This transaction was executed in multiple trades at prices ranging from $21.79 to $21.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c). Michael W. Aguiar 2011-12-13